Zainab Rayeesa, Kandasamy Arun, Bhat Naseer Ahmad, Dsouza Chrishma Violla, Jennings Hannah, Jackson Cath, Mazumdar Papiya, Hewitt Catherine Elizabeth, Ekers David, Narayanan Gitanjali, Rao Girish N, Coales Karen, Muliyala Krishna Prasad, Chaturvedi Santosh K, Murthy Pratima, Siddiqi Najma
National Institute of Mental Health and Neuro Sciences, Bangalore, India.
Jindal School of Psychology and Counselling, O P Jindal Global University, Sonipat, India.
JMIR Res Protoc. 2023 Nov 16;12:e41127. doi: 10.2196/41127.
The increasing burden of depression and noncommunicable disease (NCD) is a global challenge, especially in low- and middle-income countries, considering the resource constraints and lack of trained human resources in these settings. Effective treatment of depression in people with NCDs has the potential to enhance both the mental and physical well-being of this population. It will also result in the effective use of the available health care resources. Brief psychological therapies, such as behavioral activation (BA), are effective for the treatment of depression. BA has not been adapted in the community health care services of India, and the feasibility of using BA as an intervention for depression in NCD and its effectiveness in these settings have not been systematically evaluated.
Our objective is to adapt BA for the Indian NCD context and test the acceptability, feasibility, and implementation of the adapted BA intervention (BEACON intervention package [BIP]). Additionally, we aim to test the feasibility of a randomized controlled trial evaluation of BIP for the treatment of depression compared with enhanced usual care.
Following well-established frameworks for intervention adaptation, we first adapted BA (to fit the linguistic, cultural, and resource context) for delivery in India. The intervention was also adapted for potential remote delivery by telephone. In a randomized controlled trial, we will be testing the acceptability, feasibility, and implementation of the adapted BA intervention (BIP). We shall also test if a randomized controlled feasibility trial can be delivered effectively and estimate important parameters (eg, recruitment and retention rates and completeness of follow-up) needed to design a future definitive trial.
Following the receipt of approval from all the relevant agencies, the development of the BIP was started on November 28, 2020, and completed on August 18, 2021, and the quantitative data collection was started on August 23, 2021, and completed on December 10, 2021. Process evaluation (qualitative data) collection is ongoing. Both the qualitative and quantitative data analyses are ongoing.
This study may offer insights that could help in closing the gap in the treatment of common mental illness, particularly in nations with limited resources, infrastructure, and systems such as India. To close this gap, BEACON tries to provide BA for depression in NCDs through qualified NCD (BA) counselors integrated within the state-run NCD clinics. The results of this study may aid in understanding whether BA as an intervention is acceptable for the population and how feasible it will be to deliver such interventions for depression in NCD in South Asian countries such as India. The BIP may also be used in the future by Indian community clinics as a brief intervention program.
Clinical Trials Registry of India CTRI/2020/05/025048; https://tinyurl.com/mpt33jv5.
INTERNATIONAL REGISTERED REPORT IDENTIFIER (IRRID): DERR1-10.2196/41127.
抑郁症和非传染性疾病(NCD)的负担日益加重,这是一个全球性挑战,尤其是在低收入和中等收入国家,因为这些地区资源有限且缺乏训练有素的人力资源。有效治疗非传染性疾病患者的抑郁症有可能改善这一人群的身心健康。这也将实现现有医疗资源的有效利用。简短心理疗法,如行为激活(BA),对抑郁症治疗有效。BA尚未在印度社区医疗服务中应用,且尚未系统评估将BA用作非传染性疾病抑郁症干预措施的可行性及其在这些环境中的有效性。
我们的目标是使BA适用于印度非传染性疾病的情况,并测试改编后的BA干预措施(灯塔干预包 [BIP])的可接受性、可行性和实施情况。此外,我们旨在测试与强化常规护理相比,对BIP治疗抑郁症进行随机对照试验评估的可行性。
遵循成熟的干预措施改编框架,我们首先对BA进行改编(以适应语言、文化和资源背景)以便在印度实施。该干预措施还针对通过电话进行潜在远程实施进行了改编。在一项随机对照试验中,我们将测试改编后的BA干预措施(BIP)的可接受性、可行性和实施情况。我们还将测试随机对照可行性试验能否有效开展,并估计设计未来确定性试验所需的重要参数(如招募和留存率以及随访完整性)。
在获得所有相关机构的批准后,BIP的开发于2020年11月28日开始,并于2021年8月18日完成,定量数据收集于2021年8月23日开始,并于2021年12月10日完成。过程评估(定性数据)收集正在进行中。定性和定量数据分析均在进行中。
本研究可能提供有助于缩小常见精神疾病治疗差距的见解,特别是在像印度这样资源、基础设施和系统有限的国家。为了缩小这一差距,灯塔项目试图通过纳入国营非传染性疾病诊所的合格非传染性疾病(BA)咨询师为非传染性疾病患者的抑郁症提供BA。本研究结果可能有助于了解BA作为一种干预措施对人群是否可接受,以及在印度等南亚国家为非传染性疾病患者的抑郁症提供此类干预措施的可行性如何。BIP未来也可能被印度社区诊所用作简短干预项目。
印度临床试验注册中心CTRI/2020/05/025048;https://tinyurl.com/mpt33jv5。
国际注册报告识别码(IRRID):DERR1-10.2196/41127。